The historical rank and industry rank for Scilex Holding Co's Days Sales Outstanding or its related term are showing as below:
SCLX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 159.64 Med: 196.85 Max: 217.99
Current: 206.83
During the past 6 years, Scilex Holding Co's highest Days Sales Outstanding was 217.99. The lowest was 159.64. And the median was 196.85.
SCLX's Days Sales Outstanding is ranked worse than 93.44% of 960
companies
in the Drug Manufacturers industry
Industry Median: 72.25
vs SCLX: 206.83
Scilex Holding Co's Days Sales Outstanding
increased
from Dec. 2023 (172.93) to Dec. 2024 (177.67).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
Scilex Holding Co Days Sales Outstanding Historical Data
The historical data trend for Scilex Holding Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Scilex Holding Co's Days Sales Outstanding
For the Drug Manufacturers - General subindustry, Scilex Holding Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scilex Holding Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Scilex Holding Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Scilex Holding Co's Days Sales Outstanding falls into.
Scilex Holding Co Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scilex Holding Co (NAS:SCLX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Scilex Holding Co Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Scilex Holding Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SCLX has been successfully added to your 